GEV vs EMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 31, 2026

GEV

56.4
AI Score
VS
GEV Wins

EMR

49.0
AI Score

Investment Advisor Scores

GEV

56score
Recommendation
HOLD

EMR

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GEV EMR Winner
Revenue 20.44B 13.78B GEV
Net Income 5.41B 1.94B GEV
Net Margin 26.5% 14.1% GEV
ROE 45.3% 9.5% GEV
ROA 6.7% 4.6% GEV
Total Assets 80.80B 42.21B GEV
Current Ratio 0.85 0.90 EMR

Relative Price Performance (Last 90 Days)

GEV 1M: -9.3% · 3M: -5.5% EMR 1M: +1.7% · 3M: +7.6%

Current Technical Phase

GEV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 35.2 · Price: $898.53

EMR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.0 · Price: $152.44

Fundamentals Snapshot

Metric GEV EMR
Market Cap
Forward P/E 36.4 21.1
Trailing P/E 27.3 34.5
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.2% 0.5%
Operating Margin 0.1% 0.3%
EPS 33.38 4.50
Dividend Yield 0.00% 0.01%

Frequently Asked Questions

Based on our detailed analysis, GEV is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.